Stimulation of breast cancer cells with TGFβ results in co-localization of the matrix metalloproteinase MT1-MMP and CD44 at the cell membrane and induces CD44 cleavage resulting in high levels of soluble CD44 [15]. The gene discussed is CD44; the disease is breast carcinoma.